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Abstract 
Clinical research has demonstrated differential efficacy of selective serotonin reuptake 
inhibitors (SSRIs) and norepinephrine reuptake inhibitors (NRIs), which may relate to 
differential acute effects these medications have on emotional brain processes. Here we 
present findings from a Multi-Level Kernel Density Analysis meta-analysis that integrates 
and contrasts activations from disparate fMRI studies in order to examine whether single 
dose SSRIs and NRIs have different effects on emotion processing tasks in healthy 
participants. Seven SSRI and four NRI studies were eligible for inclusion. SSRIs decreased 
amygdala responses, suggesting reduced emotional reactivity to emotional stimuli, whereas 
NRIs increased frontal and medial activation, suggesting increased emotion regulation. As 
hypothesised, an interaction of antidepressant and task type was found, such that SSRIs 
modulated amygdaloid-hippocampal, medial and frontal activity during both the 
presentation of faces and pictures, whereas NRIs only modulated the activation in medial 
and frontal regions during the presentation of pictures. Findings are interpreted within a 
novel model of the differential effects of SSRIs and NRIs on emotion processing. 
Keywords: antidepressants; SSRI; NRI; serotonin; noradrenalin; emotion; fMRI; 
Multi-Level Kernel Density Analysis; meta-analysis 
Highlights: 
 Acute effects of antidepressants may lay the foundation for symptom amelioration. 
 Differential acute neural effects may underlie differential treatment efficacy of 
SSRIs vs NRIs. 
 We perform an fMRI meta-analysis to integrate and contrast previous findings. 
 We find that SSRIs and NRIs have differential acute neural effects. 
 We model the acute neural effects that may underlie the efficacy of SSRIs vs NRIs. 
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1. Introduction 
Affective disorders, including major depressive disorder and generalised anxiety 
disorder, are debilitating conditions with the greatest worldwide lifetime prevalence of any 
other DSM-IV disorders (Kessler et al., 2005). A key feature of affective disorders is 
dysfunctional emotion processing (Beck, 2008; Beck et al., 1979; MacLeod et al., 2002). 
Recent work has highlighted the early neural effects of antidepressants on emotion 
processing that may underpin the downstream changes associated with amelioration of 
symptoms in affective disorders (Harmer et al., 2011; 2009a; Pringle et al., 2011; Roiser et 
al., 2012). Though both selective serotonin reuptake inhibitors (SSRIs) and norepinephrine 
reuptake inhibitors (NRIs) appear to alleviate dysfunctional emotion processing (Harmer, 
2012), it is generally accepted that SSRIs are more effective than NRIs for treating affective 
disorders (Cipriani et al., 2009; 2012; Eyding et al., 2010). This differential efficacy may 
relate to specific neural effects on emotion processing. Functional neuroimaging studies 
have predominantly examined the impact of either SSRIs or NRIs on different types of 
emotion processing tasks, highlighting the need to directly contrast the neural effects of 
these antidepressant medications, taking into account task type. Here, we review the 
relevant literature, integrating and contrasting these previously reported findings, and then 
present a quantitative meta-analysis directly contrasting the effects of SSRIs and NRIs on 
commonly used affective tasks. 
Historically, the biological basis for affective disorders was related to impairment in 
monoaminergic neurotransmitter systems (Belmaker and Agam, 2008; Bunney and Davis, 
1965; Schildkraut, 1965). Current neurobiological views also highlight abnormalities in 
intracellular processes including synaptogenesis and neurogenesis (Belmaker and Agam, 
2008) in emotion-related brain regions (Duman and Monteggia, 2006), which are modulated 
by antidepressant treatment (Castrén, 2004; Duman, 2004; Warner-Schmidt and Duman, 
2006). The amygdala (AMY) and prefrontal cortex (PFC) are two regions that are 
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repeatedly implicated in affective disorders and their treatment due to the roles they play in 
emotion processing (Davidson, 2002; Davidson and Begley, 2012; Davidson et al., 2002; 
Lee et al., 2012; Mayberg, 1997; Seminowicz et al., 2004). We define emotion processing 
as a series of processes involving attentional, perceptual, appraisal, and response preparation 
operations occurring in an individual during salient internal and external events, impacting 
on the experience of and responses to the events (Gross, 1998; Gross and Thompson, 2007; 
Scherer, 2000). 
During emotion processing, the PFC has a role in appraisal and reappraisal of 
emotional stimuli (Ochsner and Gross, 2005), thereby playing both a role in the generation 
and regulation of emotional experiences (Lindquist et al., 2012; Ochsner and Gross, 2005; 
Wager et al., 2010). The AMY rapidly and reliably responds to salience of emotional stimuli 
(Luo et al., 2010; Pourtois et al., 2010) and plays a key role in emotional memory (Phelps 
and LeDoux, 2005). The reciprocal relationship between the PFC and the AMY is apparent 
during the reappraisal of emotional stimuli (Banks et al., 2007; Wager et al., 2008). A role 
of the PFC is to attenuate increased AMY activity, allowing for responses to the stimulus to 
be appropriately regulated (Banks et al., 2007; Wager et al., 2008). Depressed patients 
display reduced PFC activation and increased AMY activation at rest and during cognitive 
and emotion processing tasks, suggesting a lack of cortical regulation and inhibition of the 
AMY (Davidson and Begley, 2012; Mayberg, 2003; Siegle et al., 2007). With 
antidepressant treatment, these activations are normalised (Arnone et al., 2012; Delaveau et 
al., 2011; Godlewska et al., 2012). Other brain areas implicated in the mood and anxiety 
disorders are: the insula, linked to self-awareness and autonomic regulation of emotions 
(Craig, 2009; Paulus and Stein, 2006); the hippocampus, involved in memory formation, 
learning, sensitivity to context, and regulation of stress, as well as a major site of 
neurogenesis (Bellani et al., 2010; Brooks et al., 2012; Heijer et al., 2012); the thalamus, a 
processing center for sensation and motor regulation, which also plays a role in awareness, 
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attention, memory, and language (Herrero et al., 2002; Matsumoto et al., 2001); the 
cingulate cortex, involved in the regulation of both cognitive and emotional processing with 
functions in directed attention and motivated behaviour (Amiez et al., 2012; Blair et al., 
2012; Bush et al., 2000; Etkin et al., 2011); and the superior temporal gyrus (STG), 
implicated not only in auditory processes, but also in language processing, social cognition, 
and emotion perception in faces (Bigler et al., 2007; Domínguez-Borràs et al., 2009; Turk-
Browne et al., 2010). Furthermore, research on the treatment of affective disorders has 
demonstrated that treatment restores the function of these regions (e.g., Arce et al., 2007; 
Korb et al., 2011). 
While the precise biological mechanisms of antidepressants remain to be fully 
understood, recent theory suggests that antidepressants act by changing the way individuals 
process emotional information. More specifically, antidepressants shift the negativity bias to 
a more positive one, leading to downstream overall improvements in mood (Harmer et al., 
2011; Pringle et al., 2011). While it is generally considered that antidepressant response 
may take up to four-to-six weeks before a clinical change is apparent, an increasing body of 
work has examined the ability to predict response to antidepressant medications (Kemp et 
al., 2008; Pizzagalli, 2011). Research (e.g., Kemp et al., 2004; Kemp and Nathan, 2004; 
Murphy et al., 2009a; Norbury et al., 2007a; Rawlings et al., 2010) has revealed observable 
physiological changes occurring within hours of a single dose, suggesting the possibility 
that differential drug effects may be observed following acute rather than chronic 
administration of antidepressants prior to noticeable behavioural changes emerging. There is 
an imperative to better understand the action of different classes of antidepressant 
medications, especially considering that fewer than 40% achieve clinical remission after the 
first round of treatment (Kemp et al., 2008; Trivedi, 2006). 
1.1 Antidepressants 
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The most commonly prescribed antidepressants are SSRIs, which act through 
blocking the reuptake of serotonin (5-HT), increasing the level of 5-HT in the synapses 
(Depue and Spoont, 1986; Roseboom and Kalin, 2011; Stahl, 1998) leading to downstream 
changes, including desensitisation of 5-HT autoreceptors, restoration of function in second 
messenger systems, and transcription of neurotrophic factors, which are believed to occur 
over a similar timescale to the amelioration of symptoms (see Belmaker and Agam, 2008; 
Hyman and Nestler, 1996; Pitychoutis et al., 2012; Stahl, 1998). 5-HT cell bodies are 
located primarily in the raphe nuclei of the reticular formation in the brain stem and 
serotonergic axons innervate various other regions linked to depression and mood disorders, 
including the hypothalamus, AMY, basal ganglia, thalamus, hippocampus, cingulate cortex, 
and PFC (Gillespie et al., 2011; Stahl, 1998). These regions are consistently involved in 
emotion processing (Kober et al., 2008; Lindquist et al., 2012; Vytal and Hamann, 2010). 
Indeed, SSRI treatment is associated with the normalisation of activity in these areas (e.g., 
Di Simplicio et al., 2011; McCabe and Mishor, 2011; Murphy et al., 2009a). 
Noradrenergic reuptake inhibitors (NRIs) are another common class of 
antidepressant that block the reuptake of noradrenaline in the brain. Though downstream 
effects of NRIs have been examined less extensively than those of SSRIs, NRIs also 
produce downstream neurotropic effects (First et al., 2012). Noradrenaline (NA) is 
associated with arousal and alertness, and with other behavioural and physiological effects 
such as feeding behaviour, blood pressure, heart rate, and mood (Bönisch and Brüss, 2006). 
NA is also linked to anxiety, cognition, learning, and sleep regulation (Montgomery, 1997). 
Cell bodies are located in the locus coruleus (LC) of the brain stem with NA axons 
projecting widely to regions related to emotion processing (Kober et al., 2008; Lindquist et 
al., 2012; Vytal and Hamann, 2010); primarily the PFC, but also the AMY, cingulate cortex, 
and thalamus (Blier, 2001; Brunello et al., 2003; Haenisch and Bönisch, 2011). NRIs have 
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been reported to increase prefrontal regulation of emotional responses during exposure of 
emotional stimuli (Norbury et al., 2007a; 2007b).  
1.2 Emotional Processing Tasks 
In order to examine the effects of antidepressants on emotion processing, functional 
neuroimaging studies most frequently involve presentation of emotional pictures (IAPS; 
e.g., Brühl et al., 2011; 2010; Takahashi et al., 2005) or facial expressions (e.g., Anderson et 
al., 2007; Bigos et al., 2008; Murphy et al., 2009a). While both stimuli types are 
emotionally potent and illicit many common aspects of emotion processing involved in 
reactivity and appraisal and regulation (Bleich-Cohen et al., 2006; Britton et al., 2006b; 
Hariri et al., 2002; Lindquist et al., 2012), there are some differences. Under passive 
viewing situations, emotional facial expressions illicit more emotion recognition and 
perceptual processes (Britton et al., 2006b; Frank and Stennett, 2001; Lindquist et al., 2012) 
and are less likely to elicit emotional experience than emotional pictures (Britton et al., 
2006b; Lindquist et al., 2012). Emotionally salient pictures require more elaborated 
appraisal processes (Britton et al., 2006b; Lindquist et al., 2012), given the relatively more 
novel and complex stimulus content (Lang et al., 1993; Winston et al., 2003). Emotional 
pictures tend to be more arousing, and are more likely to elicit explicit emotional responses 
and experiences than with the perception processes involved in viewing faces (Lang et al., 
1993; Lindquist et al., 2012). Under passive viewing conditions, common and differential 
activations of pictures and faces have been reported (Bleich-Cohen et al., 2006; Britton et 
al., 2006b; Hariri et al., 2002; Lindquist et al., 2012). While both stimulus sets activate 
common regions associated with emotion processing including the AMY, hippocampus, 
ventromedial PFC, and visual cortex, faces elicit more of the components related to basic 
affective salience and perception, whereas pictures also evoke cognitive appraisal processes 
that correspond with emotional responses and experiences (Bleich-Cohen et al., 2006; 
Britton et al., 2006b; Hariri et al., 2002; Lindquist et al., 2012). Therefore, activation of 
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underlying circuitry is likely to correspond with processes such as emotion perception, 
reactivity, appraisal and regulation, and experience, rather than with discrete emotion 
categories or the type of stimulus per se (Kemp et al.,in press; Lindquist et al., 2012). 
While researchers have suggested that there are common and differential processes 
and pathways for the processing and regulation of responses to emotional faces versus 
emotional pictures, the differential impact of specific antidepressants on emotion processing 
of faces and pictures remains to be examined. While there are many other types of affective 
tasks that have been employed in functional neuroimaging studies (e.g., mood and anxiety 
inductions, social feedback/rejection, stress paradigms), only two additional studies have 
examined responses to single-dose antidepressant administration in healthy subjects. These 
studies employed tasks other than those with pictures and faces: these are Miskowiak and 
colleagues study (2007; emotional words) and the Papadatou and colleagues study (2012; 
emotional memory recall). Studies employing tasks with faces and pictures are therefore the 
most amenable to meta-analysis as they have been more frequently employed. Including 
other studies would increase heterogeneity unnecessarily. 
1.3 Present Study and Hypotheses 
The aim of the present study was to conduct a review and meta-analysis of the 
effects of acute antidepressant treatment on emotional processing, and examine the 
specificity of the effects of selective serotonin reuptake inhibitors (SSRIs) and the selective 
noradrenaline repute inhibitors (NRIs) on the processing of facial expressions versus more 
complex emotional images. It remains unclear as to whether specific classes of 
antidepressants have different effects on the processing of faces versus images. By 
enhancing understanding of the manner in which these specific medications act, we may be 
better able to understand why the clinical efficacy of SSRIs and NRIs differ (Cipriani et al., 
2012; 2009; Eyding et al., 2010). Findings will also have implications for the additional 
utility of the combined serotonin and noradrenaline reuptake inhibitors (Cipriani et al., 
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2009) and provide a neurophysiological foundation for personalised medicine in clinical 
practice. 
Our primary hypothesis was that antidepressants would modulate the activity of 
regions normally associated with emotion processing. Secondly, we hypothesised that there 
would be an interaction between drug class and task type such that the effect of an 
antidepressant would depend on the type of task presented. Based on the research (discussed 
above) linking NA and emotional pictures with responsiveness to novel stimuli and 
increased arousal, we further predicted that NRIs will modulate activity due to emotional 
pictures but not faces, while SSRIs will modulate activity in response to both emotional 
pictures and faces on the basis of their improved efficacy. 
2. Methods 
2.1. Literature Review and Study Selection 
Studies investigating the effects of antidepressants on emotional processing (as 
measured by functional magnetic resonance imaging) in healthy control subjects published 
up until April 8, 2013, were identified through a search of published reports in two major 
databases (Scopus and PubMed), using the terms: “antidepressants” AND (“functional 
magnetic resonance imaging” OR “fMRI”) AND (“emotion” OR “emotion processing”). 
Additional studies were then located by searching through the reference sections of those 
articles. We also searched for any additional publications by the authors of the papers we 
had already identified to ensure we had an exhaustive list of studies. Published reports were 
ultimately included if they met the following criteria: (1) they measured blood oxygenation 
level dependent (BOLD) response (using fMRI) to assess brain activation; (2) they involved 
healthy, unmedicated adults; (3) the antidepressant tested was either an SSRI or NRI; (3) 
they reported findings based on a single oral or intravenous dose of an antidepressant; (4) 
they involved an emotion processing task involving either facial expressions or emotional 
pictures; (5) activation was assessed using a double-blind placebo controlled experimental 
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design; (6) they provided standard Talairach or Montreal Neurological Institute (MNI) 
coordinates, allowing for comparison of findings. Studies were excluded if any participants 
were considered to be high risk for any psychiatric disorder. 
We chose studies evaluating the effects of antidepressants on healthy volunteers to 
ensure sample homogeneity and avoid issues relating to the cognitive or emotional 
functioning of study participants as well as the confounding effects of psychological or 
additional prescribed medications. While meta-analyses and reviews have been conducted 
on the effects of antidepressants on emotional processing in depressed subjects (Delaveau et 
al., 2011), no meta-analysis to date has examined the effects of more than one treatment, nor 
have the acute effects of these antidepressants in healthy controls been examined, and no 
meta-analysis to date on antidepressants has been published that utilises MKDA, a 
technique with several methodological advantages (discussed below) over alternatives.  
Based on the above criteria, there were nine studies included: five examined SSRIs 
only (Anderson et al., 2007; Bigos et al., 2008; Del-Ben et al., 2005; Murphy et al., 2009a; 
Takahashi et al., 2005), two examined NRIs only (Kukolja et al., 2008; Onur et al., 2009), 
and two examined both SSRIs and NRIs (Brühl et al., 2011; 2010). Task instructions of all 
studies included in our meta-analysis were for participants to passively view the stimuli. For 
the studies on faces, emotion categories included angry, fearful, disgusted, surprised, and 
happy faces, and their combinations used to create an emotional face condition (a 
combination of positive and negative emotion faces; Bigos et al., 2008) or an aversive face 
condition (a combination of negative emotion faces; Del-Ben et al., 2005) categories. 
Emotional face categories were always contrasted against a neutral face category. For 
studies using picture stimuli, stimuli included negative pictures high in arousal. All IAPS 
neutral stimuli conditions were low in arousal and were used to contrast the IAPS emotional 
stimuli. Studies that employed IAPS made attempts to control for content and complexity. 
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In total, there were seven studies that examined SSRIs and four studies that 
examined NRIs. There was a total of 152 subjects (103 received SSRI and 81 received 
NRI), twenty-one individual contrasts (12 SSRIs and 9 NRIs), and 121 unique coordinates 
(59 SSRIs and 62 NRIs), which were judged to be eligible for inclusion in the final analysis 
(see Figure 1 for a graphical display of the included coordinates). For each article, 
coordinates were included in the final analysis if they were considered significant by the 
criteria specified in the individual study. 
2.2 Multilevel Kernel Density Analysis (MKDA) 
The ultimate goal of this meta-analysis was to identify the regions in the brain most 
consistently modulated by emotion processing tasks while subjects were under the effects of 
a single dose of an antidepressant. Additionally, we were also interested in examining the 
differential effects of task on activation and whether there were any specific effects relating 
to the class of antidepressant (SSRI vs NRI). In order to address these objectives, we 
utilized a Multi-level Kernel Density Analysis (MKDA) to conduct our meta-analysis 
(Kober and Wager, 2010; Wager et al., 2009). MKDA is a quantitative, coordinate-based 
approach used in several recently published studies (e.g., Denny et al., 2012; Etkin and 
Wager, 2007; Kober et al., 2008). The MKDA statistic reflects the number of nominally 
independent contrast maps (i.e., statistical parametric maps from individual studies) that 
activate in the vicinity (e.g., within 10 mm) of each voxel in the brain; the null hypothesis is 
that the activation “blobs” from individual contrast maps are randomly distributed (Kober 
and Wager, 2010; Wager et al., 2009). Thus, a significant result indicates that more contrast 
maps activate near a specific voxel than expected by chance (Kober and Wager, 2010; 
Wager et al., 2009). While there are many meta-analytic methods available in neuroimaging 
research (Radua and Mataix-Cols, 2012), we selected the MKDA method for a number of 
reasons. It allows for a nested analysis of the data where multiple coordinates are nested 
within a contrast. This addresses problems associated with the non-independence of peak 
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coordinates reported by the same study, and prevents individual studies with a large number 
of activation peaks from disproportionately contributing to the results. The MKDA also 
allows the weighting of studies by sample size and effect (fixed vs. random), meaning those 
studies with a random-effects model and a larger number of participants are given more 
weight than those with a smaller sample size or fixed-effects model. A third advantage is the 
summary statistic’s clear-cut interpretability: it is simply the proportion of contrasts 
activating within 10 mm of a given voxel (Kober and Wager, 2010; Wager et al., 2009). 
Analyses were performed in MATLAB version 2011b, using the MKDA tool 
package (Wager, 2008; http://wagerlab.colorado.edu/files/tools/meta-analysis.html). Peaks 
from each study were convolved using a spherical smoothing kernel with a 10 mm radius. 
Each study was weighted by number of participants (calculated by the square root of the 
sample size) and type of analysis (where a value of 1.00 was assigned to studies using a 
random effects model and 0.75 to those with a fixed effects analysis). Contrast maps were 
weighted by sample size, rather than weighting individual peaks by Z-scores, because Z-
scores are inflated in small samples due to low degrees of freedom, and thus are not 
representative of the true effect sizes (Vul et al., 2009; Yarkoni et al., 2009). MKDA 
difference analysis was conducted in order to directly contrast the antidepressant and task 
type conditions. The threshold for statistical significance was determined using a Monte 
Carlo simulation (5000 iterations) and provided family-wise error (FWE) rate correction for 
multiple comparisons at α < .05 corrected. 
2.3 Planned comparisons 
 In order to evaluate the differential effects of antidepressant class on the two 
emotional processing tasks, we conducted additional analyses examining the interaction and 
main effects of each variable. We divided the contrasts included in our database into four 
distinct groups: SSRI Faces, SSRI Pictures, NRI Faces, and NRI Pictures, and then 
examined what the effects of each group were when contrasted against one another. This 
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provided us with an illustration of what the effects of each antidepressant had on the 
emotional processing of each task type and helped to identify any differences in mode of 
action. The proportions of contrasts that activated the obtained clusters and 95% confidence 
intervals obtained from the binomial distribution were calculated (95% CI binomial). This 
was performed in order to show the consistency of cluster activations within contrasts, 
thereby providing a measure of confidence in the obtained results. 
2.4 Description of selected studies and MKDA analyses 
Two MKDA analyses were conducted. For the first analysis, 13 contrasts 
corresponding to increased activation to emotional stimuli were included (i.e., emotional > 
neutral stimuli labelled as the Increased analysis; see Supplementary Table 1). Within this 
analysis, the contrasts were further categorised by antidepressant and task type: SSRI Faces 
= 3, SSRI Pictures = 4, NRI Faces = 3, NRI Pictures = 3. In the second analysis, 8 contrasts 
corresponding to decreased activation to emotional stimuli were included (i.e., neutral > 
emotional contrasts labelled as the Decreased analysis): SSRI Faces = 4, SSRI Pictures = 1, 
NRI Faces = 2, NRI Pictures = 1 (see Supplementary Table 2). Rather than assuming 
increases and decreases are mirror images of each other (Frankenstein et al., 2003), we 
analysed the consistency of each separately. There was no association between the numbers 
of contrasts for antidepressant class and task type for the Increased analysis (τ = .005, p = 
.805) or the Decreased analysis (τ = .022, p = .693). Therefore, any differences found 
between antidepressant classes and tasks types are unlikely to be driven by the different 
numbers of each type of contrast. 
3. Results 
3.1 Comparison of task types  
 For faces, one significant cluster (FWE-corrected level, p < .05) of increased 
activation was observed in the amygdaloid-hippocampal region (69.81% of contrasts 
activated; 95% CI binomial [24.58, 96.71]), while no significant clusters were observed in 
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the Decreased analysis. For pictures, three significant clusters were observed (p < .05; 
FWE-corrected): two encompassing the right thalamus (66.67% of contrasts activated; 95% 
CI binomial [25.25, 94.54]) and the third, surrounding the left DLPFC (74.37% of contrasts 
activated; 95% CI binomial [31.51, 97.28]). No significant clusters of activation were 
observed in the Decreased MKDA analysis. See Table 1 for the complete results. 
3.2 Comparison of antidepressant classes 
 Table 2 displays the results of the MKDA analyses for antidepressant type. The 
Increased MKDA analysis did not identify any significant clusters of increased activation 
associated with SSRI administration relative to NRIs. However, the Decreased analysis 
revealed an amygdalaloid-hippocampal cluster (100% of contrasts activated; 95% CI 
binomial [47.82, 100]), and indicated that SSRIs decrease activation in this region more 
than NRIs (p < .05; FWE-corrected). At an uncorrected (p < .01) level, the Increased 
MKDA analysis identified one cluster encompassing the left MCC, bilateral PCC, and the 
right thalamus for NRIs (66.67% of contrasts activated; 95% CI binomial [95.67, 22.28]). 
There were no significant clusters identified for decreased activation due to NRIs. 
3.3 Interaction between antidepressant class and task type 
 The Increased MKDA analysis of the 2 × 2 interaction between antidepressant 
(SSRI; NRI) and task (faces; pictures) type identified a significant left DLPFC cluster (p < 
.05; FWE-corrected), and, at an uncorrected (p < .01) level, the Decreased MKDA analysis 
of the interaction identified a significant cluster including the globus pallidus, thalamus, 
caudate, putamen, AMY, and uncus. These findings indicate specific regions in which 
differential effects of antidepressant class are moderated by task type. The Increased and 
Decreased interactions and contrast activation proportions are visualised in Figure 2, Panels 
A and B, respectively. Table 3 displays the results of the interaction as well as follow-up 
analyses. To summarise the results of the follow-up analyses (relative to NRIs), SSRIs 
decrease activation to both emotional faces and pictures in the right amydaloid-hippocampal 
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region. SSRIs also decrease activation in the left OFC, right STG, and right insula in 
response to pictures, but increase activation in the right MCC, thalamus, and caudate in 
response to pictures. In contrast, NRIs decrease activation in response to pictures only (no 
decreases for faces) when compared with SSRIs, with a significant cluster in the left STG. 
Finally, NRIs increased activation for pictures in the right thalamus, right STG, left DLPFC, 
and the left MCC and PCC. 
4. Discussion 
Here we report on findings obtained from a meta-analysis on the effects of single 
doses of two classes of antidepressants on emotion processing in healthy participants. Our 
MKDA analyses demonstrate that antidepressants have acute modulatory effects on emotion 
processing as measured by fMRI: an important finding considering that clinical change is 
not observed for up to four-to-six weeks (Kemp et al., 2008; Pizzagalli, 2011). We further 
determined that the effects of antidepressants are dependent on the antidepressant class and 
task. In the following discussion, we examine our findings in the context of previous studies 
and propose a novel model of the acute effects of SSRIs versus NRIs on emotion 
processing, taking into account different monoaminergic pathways and differential stimulus 
processing pathways. 
4.1 Findings 
Our meta-analysis revealed that emotional processing is dependent on task, 
consistent with previous findings (Bleich-Cohen et al., 2006; Britton et al., 2006b; Hariri et 
al., 2002; Lindquist et al., 2012). Passive viewing of faces increased activation in the AMY 
while pictures increased activation of the DLPFC, MCC, and thalamus. These findings are 
consistent with increased complexity of processing pictorial stimuli (Bleich-Cohen et al., 
2006; Britton et al., 2006b; 2006a; Lang et al., 1993; Lindquist et al., 2012; Winston et al., 
2003), involving the thalamus and cingulate for attentional direction and sensory 
integration, and recruitment of frontal cortical structures for increased stimulus appraisal 
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(Bleich-Cohen et al., 2006; Britton et al., 2006b; Hariri et al., 2002). Consistent with this 
interpretation, the processing of the emotional content of faces and pictures involves 
activation across regions involved in attentional, perceptual, and experiential operations, 
rather than specific activation relating to emotion category or stimulus type (Kemp et al., in 
press; Lindquist et al., 2012). Critically, we observed that brain function during the 
processing of emotional faces and pictures is modulated by administration of 
antidepressants. 
Consistent with previous research (see Delaveau et al., 2011) and models of 
antidepressant action (e.g., Pringle et al., 2011), antidepressants were found to decrease 
activation of the amygdaloid-hippocampal region and increase the activation of frontal 
regions during emotion processing. These findings may be attributed to a decrease in 
emotional reactivity (Balderston et al., 2011; LeDoux, 2007; Patin and Hurlemann, 2011) 
and an increase in regulatory processes (Grimm et al., 2006; Jung et al., 2008; Ochsner and 
Gross, 2008), respectively. These combined effects may result in decreased emotional 
reactivity, thereby helping to reduce affective disturbance in psychiatric populations with 
chronic administration. Therefore, antidepressants have acute neural effects on the 
processing of emotional stimuli, which may underpin clinical changes following chronic 
administration. A major finding obtained in our study is the differential neural effects of the 
SSRIs and NRIs. 
The present study’s findings are consistent with current models of neuroaffective 
disturbance and antidepressant action in psychiatric samples (Mayberg, 2007; 2003; 1997). 
These models characterize increases in activity of the DLPFC and decreases in amygdaloid-
hippocampal activity as a necessary change associated with treatment response and 
remission from affective disturbance. Notably, these effects are apparent upon acute 
administration of antidepressants in both healthy samples (present study) and clinical 
samples (Delaveau et al., 2011). A prior neuroimaging meta-analysis (Delaveau et al., 2011) 
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on the impact of chronic administration of antidepressants (collapsing across SSRIs, 
atypical, and SNRIs) on emotion processing (pictures and faces tasks) in patients with MDD 
reported a similar pattern of effects. Therefore, antidepressants appear to have similar 
neurophysiological effects in both healthy and clinical samples. Our study further indicates 
that these effects are presented even after acute administration of antidepressants and that 
SSRIs and NRIs have differential effects. 
Consistent with prior research (e.g., Harmer et al., 2006; Murphy et al., 2009a; 
Sheline et al., 2001), our meta-analysis demonstrated that SSRIs decrease activation to 
emotional stimuli in the amygdaloid-hippocampal region. In contrast, NRIs increased 
activation in the cingulate cortex and thalamus. Interestingly, SSRIs were found to decrease 
activation in amygdaloid-hippocampal regions when contrasted against NRIs; however, 
NRIs did not show increased or decreased activation over and above SSRIs in any region. 
These results suggest that the acute actions of SSRIs on the amygdaloid-hippocampal region 
reflect reduced early attentional processes to the salience of emotional stimuli, and thus 
reduced initial reactivity to the stimuli (Luo et al., 2010; Pourtois et al., 2010). In contrast, 
NRIs modulated the activity of medial regions: the cingulate cortex (involved in the 
cognitive regulation of emotional processing with functions in directed attention and 
motivated behaviour (Amiez et al., 2012; Blair et al., 2012; Bush et al., 2000; Etkin et al., 
2011) and the thalamus (a processing center for sensation and motor regulation, playing a 
role in awareness and attention (Herrero et al., 2002; Matsumoto et al., 2001). We interpret 
the NRI modulation of these medial regions as highlighting a role for these medications in 
the alteration of emotional stimuli on attentional load under passive viewing conditions, 
thereby increasing regulation of emotional processes, rather than attenuating the early 
reactivity associated with stimulus salience. Indeed, Murphy and colleagues (Murphy et al., 
2009b) found that citalopram (SSRI) but not reboxetine (NRI) reduced vigilance towards 
fearful faces, suggesting that citalopram modified early attentional orienting: decreasing 
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reactivity. These findings provide further support for the notion that SSRIs may have 
relatively greater anxiolytic effects than NRIs in treating the mood and anxiety disorders 
due to reductions in initial emotional reactivity (Pringle et al., 2011). Taken together, these 
differential findings may underpin increased efficacy and effectiveness of SSRIs relative to 
NRIs (Cipriani et al., 2012; 2009; Eyding et al., 2010). Our meta-analysis also revealed that 
the impact of antidepressant medication is dependent on stimulus type. 
The interaction between antidepressant and task type suggests that SSRIs and NRIs 
have differential effects dependent on whether participants are presented with emotional 
faces or pictures. The locus of this interaction for decreased activity to emotional stimuli 
was a large cluster encompassing the AMY, caudate, globus pallidus, putamen, thalamus, 
and uncus. For increased activity, the locus was the DLPFC. When this interaction was 
further examined, it was demonstrated that SSRIs had effects on both emotional pictures 
and faces while NRIs impact on responses to emotional pictures only. As SSRIs appear to 
have more extensive effects on both the amygdaloid-hippocampal region and cortical 
regions regardless of the stimulus, this may reflect an early indicator—in accordance with 
clinical findings (Cipriani et al., 2012; 2009; Eyding et al., 2010)—that SSRIs are more 
effective antidepressants than NRIs. 
4.2 Toward a model for the differential effects of 5-HT and NA augmentation on emotion 
processing 
Building on previous models (Harmer et al., 2009a; Pringle et al., 2011), we 
summarise our findings within a model of the acute effects of serotonin and norepinephrine 
on emotion processing (see Figure 2, Panel C). We suggest that augmentation of 5-HT 
impacts on emotional reactivity as well as its regulation, while NA augmentation may be 
specific to the regulation of responses to complex emotional stimuli. Models of 
antidepressant action on emotional processing have the potential to elucidate mechanisms 
underlying drug efficacy (Harmer et al., 2009a; Kemp et al., 2008; Pringle et al., 2011; 
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Roiser et al., 2012), highlighting the need to further examine the model proposed here. 
Given that the neurophysiological impacts of antidepressants are further differentiated by 
the valence of emotional stimuli (see Harmer, 2004; Harmer et al., 2009b; Kemp et al., 
2004), consistent with the notion that antidepressants potentiate positive emotion and 
suppress negative emotion (shifts in emotional bias; Harmer et al., 2009a; Pringle et al., 
2011), future modeling should consider the impact of valence of emotional stimuli on SSRI 
and NRI administration. 
4.3 Future Research 
The present study demonstrated that differential acute treatment responses to 
antidepressants may be measured using fMRI. Future research should examine whether 
these treatment-specific patterns of activation are present in clinical samples, and determine 
whether these acute treatment responses are able to help predict efficacy of chronic 
treatment. Once this has been determined, further investigation needs to establish whether 
early neural modifications in response to a course of treatment will prove more effective 
than the current practice of waiting four-to-six weeks to then decide whether the course of 
treatment requires modification. Secondly, future research is needed to examine the impact 
of SNRIs as compared to SSRIs and NRIs in order to determine the specificity of 
serotonergic and noradrenergic treatment effects. Further research is also needed on neural 
responses to positive stimuli in order to further clarify the effects of antidepressants on 
anhedonia. 
4.4 Limitations 
The present study has some limitations. First, the number of statistical parametric 
maps from the eleven examinations of SSRIs and NRIs with a total of 152 subjects on 
which analyses were conducted may be considered small. However, a similar, recent meta-
analysis reported on findings from nine studies and 126 subjects (Delaveau et al., 2011). 
While some of the results (seven out of the 79 clusters found across all analyses) were 
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significant at the p < 0.01, uncorrected level, our confidence in the obtained findings is 
reinforced by the consistency of our findings—above chance—across the studies included in 
the analyses, as shown by the proportions of contrasts found to activate the clusters (Figure 
2, Panel B). The confidence in our findings is further increased through our stringent 
methodological approach of reducing heterogeneity in our analyses by only extracting data 
from studies on healthy samples and examining tasks with emotional faces and pictures 
separately, given that responses to emotion processing tasks are heterogeneous depending 
on the task type (see Bleich-Cohen et al., 2006; Britton et al., 2006b; 2006a; Hariri et al., 
2002) and population (e.g., Keedwell et al., 2005).  
Secondly, as few studies included positive stimuli in their experimental tasks, our 
conclusions relate to the neural effects associated with the processing of negative stimuli. 
We are therefore unable to make any comment on potential differential effects of 
antidepressants on negative versus positive stimuli. More research in this area will provide 
the opportunity to examine valence as an additional factor in meta-analysis studies. 
Nevertheless, our findings demonstrate for the first time that SSRIs and NRIs have 
differential acute effects on emotion processing. Our findings provide a platform on which 
future research into specific antidepressant effects on emotion biases may be conducted. 
Future research on both healthy and clinical samples would further understanding of 
treatment mechanisms and enable exploration of treatment outcome predictors. 
4.5 Conclusion 
In conclusion, antidepressants have differential acute effects on emotion processing 
in healthy participants. Building on previous research, our novel contribution is an 
illustration of the manner in which different classes of antidepressants have specific acute 
effects on the processing of emotional faces and pictures. We propose a model of these 
differential effects on emotion processing, which needs to be further examined in healthy as 
well as clinical samples. Our findings further suggest the need to consider the impact of 
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different tasks, along with positive as well as negative valence, in order to determine the 
early effects of antidepressants on emotion processing. These findings have important 
implications for better understanding differential clinical efficacy of the SSRI versus the 
NRI class of antidepressants. 
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Figure Captions 
Figure 1. Visualisation of the coordinates included in the MKDA analyses. Red and Blue 
dots differentiate coordinates that are included in the Increased and Decreased MKDA 
analyses, respectively. 
Figure 2. Visualization of the differential acute effects impacts of SSRIs and NRIs emotion 
processing. Panel A: MKDA analysis of the antidepressant type × task type interaction 
showing increased activation cluster of left DLPFC and a decreased activation cluster of the 
right amygdaloid-hippocampal region. Panel B: Proportions of contrasts found to activate 
the clusters found in the MKDA analyses across antidepressant type × task type interaction 
conditions. Panel C: A model for the differential acute effects of acute 5-HT and NA 
augmentation on emotion processing, laying the foundation for downstream neuroadaptive 
effects and symptom amelioration. 
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